The Only Monthly Membership With a Positive ROI!

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Estrella Immunopharma

ESLANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.32

0.00500.38%

At Close: -

$1.34

0.021.13%

After Hours: Aug 12, 4:05 AM EDT

15 minutes delayed

Estrella Immunopharma (ESLA) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Estrella Immunopharma (NASDAQ:ESLA) Stock

Estrella Immunopharma Stock (NASDAQ: ESLA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 14, 2024

Estrella Immunopharma Appoints Hong Zhang As ...
Benzinga Newsdesk

Tuesday, March 26, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Friday, March 08, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Wednesday, January 17, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Tuesday, January 16, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Friday, January 12, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Wednesday, January 10, 2024

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Tuesday, January 02, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Monday, December 04, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Friday, November 24, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Thursday, October 05, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved